Advances in stem cell research have raised the prospect of a breakthrough in the treatment of Parkinson’s disease, Nobel laureate Randy Schekman told the Central News Agency in an interview during a visit to Taipei last month.
“We still have to know a lot about the pathology of Parkinson’s disease,” Schekman said on April 26, adding that he believes embryonic stem cell research would likely lead to the next big clinical breakthrough for the disease.
Schekman, who shared the 2013 Nobel Prize for Physiology or Medicine with fellow American James Rothman, a biochemist, and German-American biochemist Thomas Sudhof, for solving the mystery of how a cell organizes its transport system, is now leading a major effort to study Parkinson’s.
The study is funded by Google cofounder Sergey Brin, who has donated heavily to Parkinson’s research ever since he was found in 2008 to have a gene mutation that leaves him with a higher possibility of contracting the disease.
There are a number of investigators in Asia and around the world exploring the use of induced pluripotent stem cells (iPS cells) — a discovery made by Japanese stem cell researcher Shinya Yamanaka in 2006 — to devise treatment for Parkinson’s, Schekman said.
Parkinson’s disease is primarily caused by deficiency in dopamine produced by dopaminergic neurons in the brain.
It is possible to turn adult cells taken from a Parkinson’s patient into an embryonic-like state in the laboratory and convert them into, for instance, dopaminergic neurons to be implanted back into the brain of the patient to restore the dead dopaminergic neurons, Schekman said.
The use of iPS technology in the disease “is still being actively researched, but there is some promise,” he said. “This is something I think deserves more support.”
A new technology to grow iPS cells into three-dimension mini organs, instead of flat surface, in a laboratory also allows investigators to further explore the nature of the disease, he added.
Schekman, a professor of molecular and cell biology at the University of California, Berkeley, had a personal connection with the disease because his wife, Nancy Walls, was diagnosed with Parkinson’s when she was 48.
She died on Sept. 7 last year, about seven weeks shy of her 69th birthday.
After decades of work on yeast to identify the pathway of protein export and showing that it is similar to the pathway in human cells, Schekman said he has moved on to working on human cultured cells, focusing on extracellular vesicles.
Extracellular vesicles are tiny membrane-enclosed particles released from cells that transport molecules such as ribonucleic acid (RNA) outside of the cells as a form of intercellular communication.
The study of extracellular vesicles that carry RNAs secreted by cells and circulate in bodily fluids could help early diagnosis of cancer, Schekman said.
“It has been discovered that the RNAs you can find in human serum change during metastatic cancer, so the biotechnology industry is very interested in using these RNAs as a diagnostic tool, maybe even for very early diagnosis of cancer,” he said.
Schekman visited Taiwan at the invitation of the Tang Prize Foundation. He is a member of the foundation’s international advisory board.
Starlux Airlines, Taiwan’s newest international carrier, has announced it would apply to join the Oneworld global airline alliance before the end of next year. In an investor conference on Monday, Starlux Airlines chief executive officer Glenn Chai (翟健華) said joining the alliance would help it access Taiwan. Chai said that if accepted, Starlux would work with other airlines in the alliance on flight schedules, passenger transits and frequent flyer programs. The Oneworld alliance has 13 members, including American Airlines, British Airways, Cathay Pacific and Qantas, and serves more than 900 destinations in 170 territories. Joining Oneworld would also help boost
A new tropical storm formed late yesterday near Guam and is to approach closest to Taiwan on Thursday, the Central Weather Administration (CWA) said. Tropical Storm Pulasan became the 14th named storm of the year at 9:25pm yesterday, the agency said. As of 8am today, it was near Guam traveling northwest at 21kph, it said. The storm’s structure is relatively loose and conditions for strengthening are limited, WeatherRisk analyst Wu Sheng-yu (吳聖宇) said on Facebook. Its path is likely to be similar to Typhoon Bebinca, which passed north of Taiwan over Japan’s Ryukyu Islands and made landfall in Shanghai this morning, he said. However, it
Taiwan's Gold Apollo Co (金阿波羅通信) said today that the pagers used in detonations in Lebanon the day before were not made by it, but by a company called BAC which has a license to use its brand. At least nine people were killed and nearly 3,000 wounded when pagers used by Hezbollah members detonated simultaneously across Lebanon yesterday. Images of destroyed pagers analyzed by Reuters showed a format and stickers on the back that were consistent with pagers made by Gold Apollo. A senior Lebanese security source told Reuters that Hezbollah had ordered 5,000 pagers from Taiwan-based Gold Apollo. "The product was not
COLD FACTS: ‘Snow skin’ mooncakes, made with a glutinous rice skin and kept at a low temperature, have relatively few calories compared with other mooncakes Traditional mooncakes are a typical treat for many Taiwanese in the lead-up to the Mid-Autumn Festival, but a Taipei-based dietitian has urged people not to eat more than one per day and not to have them every day due to their high fat and calorie content. As mooncakes contain a lot of oil and sugar, they can have negative health effects on older people and those with diabetes, said Lai Yu-han (賴俞含), a dietitian at Taipei Hospital of the Ministry of Health and Welfare. “The maximum you can have is one mooncake a day, and do not eat them every day,” Lai
RSS